CONDITION GUIDE · DC 6602

Asthma: understand the requirements.

Read the clinical findings used to evaluate Asthma, then compare them with the VA rating criteria under DC 6602.

What establishes the diagnosis?

Asthma — diagnostic reference

Partial diagnostic criteria

Adults; asthma only

GINA 2026 strategy report and summary guide

Symptoms and airflow variability

Compatible variable respiratory symptoms plus evidence of variable expiratory airflow limitation.

Frequently Asked Questions ↗ · How is asthma diagnosed?

Objective assessment

Spirometry with bronchodilator comparison, peak-flow assessment or selected challenge testing supports evaluation; FeNO assesses airway inflammation.

Asthma: Diagnosis ↗ · Diagnostic tests

Adult bronchodilator response

With compatible variable symptoms: FEV1 or FVC increase ≥12% AND ≥200 mL from baseline; PEF increase ≥20% is an alternative when spirometry is unavailable.

2026 GINA Summary Guide ↗ · Table 1, p. 8; pp. 9–10

Other objective variability routes

Adult routes include average daily PEF variability >10% across two weeks; four-week ICS response ≥12% and ≥200 mL in FEV1 or FVC; or between-visit FEV1 change ≥12% and ≥200 mL. PEF alternatives use ≥20%. Standardized bronchial challenge is another route.

2026 GINA Summary Guide ↗ · Table 1, p. 8; pp. 9–10

Testing and differential context

Apply source-specific measurement protocols; PEF is less reliable. Negative testing can require reassessment during symptoms. Biomarkers support Type 2 asthma but neither establish asthma alone nor exclude it when low. Consider COPD, cardiac disease and cough mimics; treated patients need a separate confirmation pathway.

2026 GINA Summary Guide ↗ · Table 1, p. 8; pp. 9–10

Confirmation after inhaled corticosteroids

Treatment can suppress airflow variability. Review earlier spirometry and the timing of inhalers. If symptoms persist, repeat testing during symptoms or after a clinician-directed bronchodilator hold appropriate to the drug.

Global Strategy for Asthma Management and Prevention ↗ · Boxes 1-4 and 1-5, diagnostic confirmation during ICS treatment

When initial testing is inconclusive

For few symptoms and lung function above 70% predicted, the clinician may supervise a treatment reduction with a written action plan and repeat testing in 2–4 weeks. With frequent symptoms and lung function below 70% predicted, the clinician may increase treatment and reassess in 1–2 months. Persistent uncertainty warrants specialist evaluation.

Global Strategy for Asthma Management and Prevention ↗ · Boxes 1-4 and 1-5, diagnostic confirmation during ICS treatment
2026 GINA Summary Guide ↗ · How to confirm the diagnosis of asthma in patients taking ICS, p. 9

Adult challenge results

Interpret the fall in FEV1 against the challenge used. Methacholine uses at least 20%. Standardized mannitol, hypertonic saline or hyperventilation uses at least 15%. With standardized exercise, both a fall greater than 10% and a drop greater than 200 mL are required. The laboratory checks test quality and clinical suitability.

Global Strategy for Asthma Management and Prevention ↗ · Box 1-2, adult bronchial provocation

Clues to another cause

Inspiratory noise during exertion suggests inducible laryngeal obstruction. Daily sputum or recurrent infection warrants evaluation for bronchiectasis. Breathlessness when lying flat or ankle swelling supports cardiac assessment. In a person with smoking or occupational exposure, evaluate persistent airflow obstruction for COPD.

Global Strategy for Asthma Management and Prevention ↗ · Box 1-3, differential diagnosis in adults

Challenge test safety

The laboratory screens baseline lung function, ability to repeat spirometry and cardiovascular risks. ERS advises against incremental challenge with adult pre-test FEV1 below 60% predicted or below 1.5 L. Exercise and voluntary hyperpnoea challenge use a 75%-predicted safety boundary. Refer recent stroke or myocardial infarction, uncontrolled hypertension and other contraindications to the supervising clinician.

Technical standard for methacholine challenge testing ↗ · Table 1, Contraindications; Patient safety; test procedure step 11

Supervision and recovery

A trained team must be ready to reverse bronchoconstriction and respond to an emergency. At the protocol endpoint, stop the challenge, give the rescue bronchodilator and repeat spirometry to document recovery before discharge. The testing laboratory sets agent-specific dosing, medication holds and discharge criteria.

Technical standard for methacholine challenge testing ↗ · Table 1, Contraindications; Patient safety; test procedure step 11

Testing during pregnancy

Use symptom history and available objective airflow measurements. Bronchial provocation is contraindicated during pregnancy. Avoid reducing inhaled corticosteroid treatment merely to demonstrate variability. If the history supports asthma and objective confirmation is still needed, maintain clinician-directed care and arrange confirmation after delivery.

Global Strategy for Asthma Management and Prevention ↗ · Chapter 1, Confirming the diagnosis in specific populations: pregnant women

Severe asthma work-up

First verify the diagnosis, inhaler technique, adherence, exposures and comorbidities. In severe asthma on high-dose inhaled treatment, evidence of Type 2 inflammation can include blood eosinophils ≥150/µL, exhaled nitric oxide ≥20 ppb, sputum eosinophils ≥2%, or a convincing allergen-driven pattern. Oral corticosteroids may suppress biomarkers. A specialist can repeat measurements up to three times, preferably before a course or at least one to two weeks afterward, or on the lowest feasible dose. Biologic eligibility requires separate criteria.

Difficult-to-Treat and Severe Asthma ↗ · Figure 3 and sections 5–7, investigation and assessment of phenotype

Scope of this clinical reference

  • The specialist laboratory determines individual contraindications, dosing and recovery. Local biologic eligibility and pregnancy-specific care require clinical review.
Frequently Asked Questions ↗ · How is asthma diagnosed?
Asthma: Diagnosis ↗ · Diagnostic tests
Global Strategy for Asthma Management and Prevention ↗ · Boxes 1-4 and 1-5, diagnostic confirmation during ICS treatment · Box 1-2, adult bronchial provocation · Box 1-3, differential diagnosis in adults · Chapter 1, Confirming the diagnosis in specific populations: pregnant women
Technical standard for methacholine challenge testing ↗ · Table 1, Contraindications; Patient safety; test procedure step 11
Difficult-to-Treat and Severe Asthma ↗ · Figure 3 and sections 5–7, investigation and assessment of phenotype

How is it connected to service?

The applicable direct, secondary, aggravation or presumptive route determines the service-connection evidence. Use the evidence guide to distinguish these routes.

Explore service-connection evidence →

What do the rating levels describe?

A diagnosis does not automatically establish a percentage. These are the source requirements for evaluating severity; related notes and exceptions still apply.

0%

A 0% evaluation may apply when the requirements for a compensable rating are not met, under §4.31.

    10%

    The 10% criteria include an intermittent bronchodilator route or either of these lung-function thresholds.

    • Intermittent inhaled or oral bronchodilator treatment.
    • FEV-1 at 71–80% of the predicted value.
    • FEV-1/FVC ratio at 71–80%.

    30%

    Treatment can support this level even when the lung-function route is not the applicable one.

    • Daily inhaled or oral bronchodilator treatment, or inhaled anti-inflammatory medication.
    • FEV-1 at 56–70% of the predicted value.
    • FEV-1/FVC ratio at 56–70%.

    60%

    The rule provides alternative treatment and lung-function routes at 60%.

    • At least monthly physician visits for required care of exacerbations.
    • At least three courses per year of systemic corticosteroids, taken orally or by injection.
    • FEV-1 at 40–55% predicted, or FEV-1/FVC at 40–55%.

    100%

    The highest asthma tier includes any of the listed alternative routes, supported by the record.

    • FEV-1 below 40% predicted, or FEV-1/FVC below 40%.
    • More than one attack per week with episodes of respiratory failure.
    • Daily systemic high-dose corticosteroids or immunosuppressive medication.
    Compare these levels with the original rating table

    Find DC 6602 in the rating schedule

    The highlighted row marks this code. Nearby rows provide context and can describe other conditions. Use the full schedule for applicable headings, footnotes and exceptions.

    38 CFR Part 4 · excerpt surrounding DC 6602
    Rating
    Or rate according to pulmonary impairment as for chronic bronchitis (DC 6600).
    Note: An incapacitating episode is one that requires bedrest and treatment by a physician.
    6602 Asthma, bronchial:
    FEV-1 less than 40-percent predicted, or; FEV-1/FVC less than 40 percent, or; more than one attack per week with episodes of respiratory failure, or; requires daily use of systemic (oral or parenteral) high dose corticosteroids or immuno-suppressive medications100
    FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to 55 percent, or; at least monthly visits to a physician for required care of exacerbations, or; intermittent (at least three per year) courses of systemic (oral or parenteral) corticosteroids60
    FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to 70 percent, or; daily inhalational or oral bronchodilator therapy, or; inhalational anti-inflammatory medication30
    FEV-1 of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to 80 percent, or; intermittent inhalational or oral bronchodilator therapy10
    Note: In the absence of clinical findings of asthma at time of examination, a verified history of asthmatic attacks must be of record.
    6603 Emphysema, pulmonary:

    How VA handles coexisting respiratory conditions

    When more than one listed respiratory condition is present, check the predominant-disability rule before combining ratings. The special pulmonary-function-test provisions apply only to the codes listed in subsection (d).

    Read 38 CFR §4.96 ↗
    Related notes and evaluation rules

    Note: In the absence of clinical findings of asthma at time of examination, a verified history of asthmatic attacks must be of record.

    Official rating schedule · DC 6602, §4.97 ↗

    What can professional assessments clarify?

    Spirometry with bronchodilator assessment

    Expiratory airflow and change after bronchodilator

    The role depends on the condition and clinical pathway below; this is not a universal VA claim requirement.

    Bronchoprovocation assessment

    Airway responsiveness

    The role depends on the condition and clinical pathway below; this is not a universal VA claim requirement.

    Serial peak expiratory flow assessment

    Variable expiratory airflow

    The role depends on the condition and clinical pathway below; this is not a universal VA claim requirement.

    Severe asthma phenotype assessment

    Inflammatory and treatable traits after confirming asthma

    The role depends on the condition and clinical pathway below; this is not a universal VA claim requirement.

    A test score alone does not establish a VA percentage or service connection.

    Which evidence addresses the questions?

    • Diagnosis and history: Records identifying the current respiratory diagnosis, diagnosis date, onset, course, and relevant treatment history.
    • Pulmonary function tests: Pulmonary function testing or spirometry reports containing measurements relevant to asthma evaluation.
    • Treatment and medications: Medication lists, prescriptions, pharmacy records, and treatment notes describing asthma therapy and frequency of use.
    • Exacerbations and physician visits: Treatment records documenting asthma attacks, respiratory failure, exacerbations, emergency care, and required physician visits.
    • Service event and exposure: Service records and lay or medical evidence describing onset, relevant duties, respiratory events, or qualifying exposures during service.
    • Medical connection evidence: Medical opinions and supporting records addressing a relationship between the current asthma condition and service or another service-connected condition.
    Find evidence in the Respiratory Conditions (other than tuberculosis and sleep apnea) questionnaire

    Use these section names and page numbers to locate the examiner’s findings. Some sections apply only to particular diagnoses within this family.

    • diagnosis · p. 1, 2
    • medical history · p. 3, 4
    • pulmonary conditions · p. 4, 5, 6, 7, 8, 9
    • diagnostic testing · p. 9, 10, 11
    • functional impact · p. 11
    • remarks · p. 11
    Read the official Respiratory Conditions (other than tuberculosis and sleep apnea) questionnaire ↗

    Shared library and examination references

    How an independent medical review works →

    Sources and scope

    Clinical and evidence sources
    Frequently Asked Questions ↗ · How is asthma diagnosed?
    Asthma: Diagnosis ↗ · Diagnostic tests
    Global Strategy for Asthma Management and Prevention ↗ · Boxes 1-4 and 1-5, diagnostic confirmation during ICS treatment · Box 1-2, adult bronchial provocation · Box 1-3, differential diagnosis in adults · Chapter 1, Confirming the diagnosis in specific populations: pregnant women
    Technical standard for methacholine challenge testing ↗ · Table 1, Contraindications; Patient safety; test procedure step 11
    Difficult-to-Treat and Severe Asthma ↗ · Figure 3 and sections 5–7, investigation and assessment of phenotype

    Guide source check: 2026-11-06. Rating-library snapshot: June 30, 2026. Source coverage is distinct from clinical review. This page does not diagnose, adjudicate a claim, or collect medical records.

    Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.

    About these educational tools

    The calculator and guides provide general education, not medical, legal, or financial advice. Using them does not create a clinician-patient, evaluator-evaluee, or attorney-client relationship. Professional services require a separate accepted engagement.

    VA determines eligibility, service connection, ratings, qualifying dependents, effective dates, and the amount payable. Using these tools does not submit a claim or appeal.

    Diagnosis, connection to service, and severity are separate questions. Matching a description or screening score does not establish a diagnosis or entitlement. A qualified clinician should interpret medical findings. Do not change treatment based on these guides.

    Ingleside Health is an independent physician service, not a law firm or VA-accredited claims representative. It is not affiliated with or endorsed by VA and does not prepare, present, prosecute, or file benefits claims.

    Do not rely on an estimate alone for financial commitments or claim decisions. Check official VA information and seek appropriate individual advice.

    Calculation assumptions and exclusions
    • Basic compensation estimate. Special Monthly Compensation (SMC), Total Disability based on Individual Unemployability (TDIU), offsets or recoupment, back pay, temporary total ratings, and unsupported adult-dependent categories are not calculated.
    • Bilateral handling covers the supported arm/leg selections. Other paired skeletal muscles, amputation limits, and overlapping manifestations need individual review. The tool cannot determine whether every entered rating may be separately combined.
    • Use separately established evaluations or clearly hypothetical percentages. Choosing a condition or percentage does not establish diagnosis, service connection, or entitlement.
    • Uses 2026 compensation rates effective December 1, 2025. Historical payments, future rate changes, and individual effective dates are not calculated. See the source dates on each reference; rules and rates may change.
    Using the website or a chat tool

    Calculator selections stay in this browser tab's memory and are not saved or submitted as intake. Refreshing the page resets the example. Do not enter personal records or identifiers. Website visits remain subject to the Website Privacy Policy.

    Use hypothetical scenarios only in chat tools. Do not send records, identifiers, symptoms, or real case information. The chat provider's own terms and privacy settings apply; a chat conversation is not the Box-hosted clinical intake.

    Accredited Veterans Service Organization (VSO) representatives provide free help with VA benefit claims. Find VA-accredited help. Read VA’s official rating guidance.

    Terms of UseWebsite Privacy PolicyAccessibility and help

    This business is not endorsed or sponsored by, or affiliated with, the United States Department of Veterans Affairs or the Illinois Department of Veterans Affairs, or any federally chartered VA accredited veteran service organization. You may qualify for other veterans benefits beyond the benefits for which you are receiving services here.

    Veteran and military benefits services are available free of charge from VA accredited county veteran service officers, representatives of the Illinois Department of Veterans Affairs, and the veteran service officers of federally chartered veteran service organizations. To learn more, contact these organizations or the Illinois Attorney General's Office at 1-800-382-3000.